Kairos Pharma (KAPA) Company Overview

Profile

Full Name:

Kairos Pharma

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 16, 2024

Indexes:

Not included

Description:

Kairos Pharma is a biotechnology company focused on developing innovative therapies for various diseases, aiming to improve patient outcomes through advanced research and drug development.

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 26, 25 D. Boral Capital
Buy
Feb 18, 25 D. Boral Capital
Buy
Feb 12, 25 D. Boral Capital
Buy
Jan 22, 25 D. Boral Capital
Buy
Nov 14, 24 D. Boral Capital
Buy
Oct 14, 24 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Kairos Pharma?
  • Does Kairos Pharma pay dividends?
  • What sector is Kairos Pharma in?
  • What industry is Kairos Pharma in?
  • What country is Kairos Pharma based in?
  • When did Kairos Pharma go public?
  • Is Kairos Pharma in the S&P 500?
  • Is Kairos Pharma in the NASDAQ 100?
  • Is Kairos Pharma in the Dow Jones?
  • When was Kairos Pharma's last earnings report?
  • When does Kairos Pharma report earnings?
  • Should I buy Kairos Pharma stock now?

What is the ticker symbol for Kairos Pharma?

The ticker symbol for Kairos Pharma is NYSE American:KAPA

Does Kairos Pharma pay dividends?

No, Kairos Pharma does not pay dividends

What sector is Kairos Pharma in?

Kairos Pharma is in the Healthcare sector

What industry is Kairos Pharma in?

Kairos Pharma is in the Biotechnology industry

What country is Kairos Pharma based in?

Kairos Pharma is headquartered in United States

When did Kairos Pharma go public?

Kairos Pharma's initial public offering (IPO) was on September 16, 2024

Is Kairos Pharma in the S&P 500?

No, Kairos Pharma is not included in the S&P 500 index

Is Kairos Pharma in the NASDAQ 100?

No, Kairos Pharma is not included in the NASDAQ 100 index

Is Kairos Pharma in the Dow Jones?

No, Kairos Pharma is not included in the Dow Jones index

When was Kairos Pharma's last earnings report?

Kairos Pharma's most recent earnings report was on Nov 14, 2024

When does Kairos Pharma report earnings?

The next expected earnings date for Kairos Pharma is Mar 14, 2025

Should I buy Kairos Pharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions